Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 2
2018 3
2019 6
2020 3
2021 1
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
SGLT2 Inhibition and Uric Acid Excretion in Patients with Type 2 Diabetes and Normal Kidney Function.
Suijk DLS, van Baar MJB, van Bommel EJM, Iqbal Z, Krebber MM, Vallon V, Touw D, Hoorn EJ, Nieuwdorp M, Kramer MMH, Joles JA, Bjornstad P, van Raalte DH. Suijk DLS, et al. Among authors: van baar mjb. Clin J Am Soc Nephrol. 2022 May;17(5):663-671. doi: 10.2215/CJN.11480821. Epub 2022 Mar 23. Clin J Am Soc Nephrol. 2022. PMID: 35322793 Free PMC article. Clinical Trial.
The renal hemodynamic effects of the SGLT2 inhibitor dapagliflozin are caused by post-glomerular vasodilatation rather than pre-glomerular vasoconstriction in metformin-treated patients with type 2 diabetes in the randomized, double-blind RED trial.
van Bommel EJM, Muskiet MHA, van Baar MJB, Tonneijck L, Smits MM, Emanuel AL, Bozovic A, Danser AHJ, Geurts F, Hoorn EJ, Touw DJ, Larsen EL, Poulsen HE, Kramer MHH, Nieuwdorp M, Joles JA, van Raalte DH. van Bommel EJM, et al. Among authors: van baar mjb. Kidney Int. 2020 Jan;97(1):202-212. doi: 10.1016/j.kint.2019.09.013. Epub 2019 Oct 10. Kidney Int. 2020. PMID: 31791665 Free article. Clinical Trial.
GLP-1 receptor agonists, CKD, and eGFR trajectory.
van Baar MJB, van Raalte DH, Muskiet MHA. van Baar MJB, et al. Lancet Diabetes Endocrinol. 2018 Oct;6(10):764-765. doi: 10.1016/S2213-8587(18)30241-9. Lancet Diabetes Endocrinol. 2018. PMID: 30266180 No abstract available.
Renal outcomes in CVOTs: keep calm and carry on.
Muskiet MHA, van Baar MJB, Scholtes RA, van Raalte DH. Muskiet MHA, et al. Among authors: van baar mjb. Lancet Diabetes Endocrinol. 2018 Sep;6(9):674-676. doi: 10.1016/S2213-8587(18)30195-5. Epub 2018 Jun 21. Lancet Diabetes Endocrinol. 2018. PMID: 29937268 No abstract available.
16 results